EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Distinct CFTR Mutation Spectrum and Atypical Clinical Presentations in Chinese Patients with Cystic Fibrosis

Zixin Wang, Guizhi Zuo, Ye Shi, Yinghao Zhao, Xue Fan, Xia Hou, Qingtian Wu

International Journal of Molecular Sciences · 18.03.2026 · 27 (6) · 2770

DOI: 10.3390/ijms27062770 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.03.2026. Verfasst von Zixin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Jiamusi University, Jiamusi 154007, China. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is an autosomal recessive disorder caused by pathogenic variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and primarily affects the respiratory, digestive, and reproductive systems. Globally, CF is most prevalent among European ancestry, with an incidence rate of approximately 1/2500 to 1/3500. In China, the incidence is about 1/128,000. However, CF is not extremely rare in the Chinese population; rather, its prevalence is significantly underestimated. The CFTR mutation spectrum in China is highly unique, characterized by an extremely low frequency of p.Phe508del. Instead, region-specific mutations such as p.Gly970Asp, p.Ile1023Arg, and p.Arg553Ter predominate, alongside a high proportion of splicing variants and complex rearrangements. A significant proportion of Chinese CF patients primarily present with CF-like phenotypes within the CF-related disease spectrum (such as congenital bilateral absence of the vas deferens and pseudo-Bartter syndrome), exhibiting overlapping features with classic CF but lacking typical respiratory-dominant symptoms. This review examines how these atypical symptoms deviate from the diagnostic pathways established in Western countries. Establishing localised data and functional platforms is a prerequisite for achieving precision medicine. Achieving a transition from symptom-focused care to defect-correcting therapy will require coordinated multicenter collaboration and sustained infrastructure development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorMutationHumansChinaPhenotypeEast Asian People

Stichwörter der Autor:innen

CFTR mutationsChinese populationcystic fibrosismutation spectrum

Substanzen

CFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • School of Basic Medicine, Jiamusi University, Jiamusi 154007, China.

Förderung

  • Natural Science Foundation of Heilongjiang Province, China

Zitieren

APA

Wang, Z., Zuo, G., Shi, Y., Zhao, Y., Fan, X., Hou, X., & Wu, Q. (2026). Distinct CFTR Mutation Spectrum and Atypical Clinical Presentations in Chinese Patients with Cystic Fibrosis. International Journal of Molecular Sciences, 27(6), 2770. https://doi.org/10.3390/ijms27062770

Vancouver

Wang Z, Zuo G, Shi Y, Zhao Y, Fan X, Hou X, et al. Distinct CFTR Mutation Spectrum and Atypical Clinical Presentations in Chinese Patients with Cystic Fibrosis. International Journal of Molecular Sciences. 2026;27(6):2770. doi:10.3390/ijms27062770

BibTeX
@article{Wang2026,
  author = {Wang, Zixin and Zuo, Guizhi and Shi, Ye and Zhao, Yinghao and Fan, Xue and Hou, Xia and Wu, Qingtian},
  title = {Distinct CFTR Mutation Spectrum and Atypical Clinical Presentations in Chinese Patients with Cystic Fibrosis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2770},
  doi = {10.3390/ijms27062770}
}
Kostenlos starten →